Andrew Morris is the Professor of Diabetic Medicine and Head of Planning and Development in the College of Medicine Dentistry and Nursing at the University of Dundee. He leads a translational research team that focuses on the epidemiological and molecular aetiological basis of diabetes and its complications. He also has a major interest in how managed clinical networks can improve patient care across geographical boundaries. He leads the internationally acclaimed DARTS research study, has published over 170 original papers and has attracted over £20 million in peer reviewed grant funding. He is the principal investigator on many clinical studies of new therapeutics of diabetes as well as genetics of diabetes, including the Wellcome Trust United Kingdom Case Control Collection for Type 2 Diabetes that is recruiting 15,000 individuals. He is also the principal investigator of Generation Scotland, a study of the genetic health in 50,000 Scots. He was awarded the RD Lawrence Award by Diabetes UK in 2003, the Saltire Society Scottish Science Award in 2005 and is a Fellow of the Royal Society of Edinburgh, Scotland’s national academy of science and letters. He was appointed by the Minister for Health and Community Care to be Lead Clinician for diabetes in Scotland (2002-2006) and led a national programme of quality improvement in diabetes care. He is also the eHealth Director of NHS Tayside and chairs the Translational Medicine Research Collaboration Steering Group, unique £50 million collaboration between all Medical Schools in Scotland and the pharmaceutical giant Wyeth. Recently he has been appointed as a Chairman of The Wellcome Trust Expert Review Group – Genetics, Genomics and Population Research.